Introduction {#s1}
============

Changes in lifestyle and in the availability and quality of food largely explain the worldwide epidemic of obesity ([@B1]). However, high variability exists in individual susceptibility to develop overweight in an obesogenic environment ([@B2]). This implies that genetic risk factors among individuals substantially influence the variability in body mass index ([@B3]). A better understanding of the molecular basis of this heterogeneity might help to fight against obesity and its related disorders. In the past, numerous animal models have been used to investigate pre-existing differences that are established before the onset of corpulence and that confer a risk for common obesity ([@B4]--[@B7]). In this way, prospective studies in rats have shown that some early metabolic responses to high fat diet (HFD) at normal weight are predictive of propensity to develop obesity and liver diseases on the long term ([@B8]--[@B11]). In the present study, we found in mice that aberrant feeding behavior in response to dietary fat constitutes a latent vulnerability trait to obesity. This predictive model can be relevant to identify biological risk factors for maladpative eating behaviors and obesity before the onset of the disease. Recent genetic studies in human indicated that most of the genes associated to the body mass index are enriched in the brain and related to neuronal biology and synaptic plasticity ([@B12], [@B13]). Thus, we further examined the expression of polysialic acid-neural cell adhesion molecule (PSA-NCAM), a marker of neural plasticity, in mice prone to obesity, and we found that the vulnerability to obesity was correlated with decreased hypothalamus level of PSA-NCAM.

Methods {#s2}
=======

Animals
-------

Protocols including manipulation of animals (registration number 853.01) were reviewed and approved by our local Institutional Animal Care and Use Committee ("Comité d\'éthique en expérimentation animale n°105"), and were in strict accordance with the European Community guidelines (directive 86/906). Experiments were carried out with 2 months-old male C57Bl/6JOla mice from Harlan Laboratories. Mice were housed individually, fed either a standard diet (catalog number A04; Safe Laboratories; Augy, France; 3.3 kcal/kg; energy from carbohydrate/fat/protein: 72.4/8.4/19.3) or a customized highly palatable high-fat diet (catalog number U8954P V.7; Safe Laboratories; 4.4 kcal/kg; energy from carbohydrate/fat/protein: 40.8/42.9/16.3). Free access was given for food and water. Recordings of food intake and body weight were done manually at 9:00 h. For tissue collection, mice were killed between 14:00 and 16:00 h after a 6-h fast.

Medio-Basal Hypothalamus Dissection
-----------------------------------

After sacrifice, brains were quickly removed and immersed in cold PBS solution. A 2 mm coronal slice was cut with a brain matrix. The slice was laid on a 6% agarose block and the MBH was dissected under stereomicroscope and cold-light illumination using a scalpel. Tissues were immediately frozen in liquid nitrogen and stored at −80°C until experiments.

PSA-NCAM Assay
--------------

Tissues were lysed and homogenized in RIPA lysis buffer using the TissueLyser system (Qiagen; Courtaboeuf, France) and 5 mm stainless steel beads (Qiagen). The homogenates were centrifuged 5 min at 5,000 *g* and supernatants were collected for PSA-NCAM assay using an enzyme-linked immunosorbent assay kit (PSA NCAM ELISA kit; Eurobio; Courtaboeuf, France) and for protein assay (Bio-Rad Protein Assay Kit ll; Biorad; Marnes-la-Coquette, France).

Statistical Analysis
--------------------

All data are expressed as means. Error bars indicate standard errors of the mean (SEM). Multiple comparisons between groups were carried out by one- or two-way ANOVA using Prism 5.0 software (GraphPad Software; San Diego, CA, United States). *Post-hoc* analyses were done when main effects reached significance. Before comparison, Bartlett\'s and Shapiro--Wilk\'s tests were applied to check equality of variances and to evaluate the normality of the distribution, respectively.

Results {#s3}
=======

The Homeostatic Feeding Response to a Dietary Fat Challenge Reveals Obesity Susceptibility
------------------------------------------------------------------------------------------

For a 2-month old mice fed with standard diet, the typical daily energy intake is 0.5 kcal per gram of body weight (The Jackson Laboratory, Mouse Phenome Database, <http://phenome.jax.org/>). It is well-known that high-energy foods cause transient overeating in most of the mice, which corresponds to an acute increase in energy intake during a few days ([@B14]--[@B16]), as illustrated in Figure [S1A](#SM1){ref-type="supplementary-material"}. In this study, the period of overconsumption was variable between mice and normalization of energy intake occurred after 2 days or more (Figure [S1B](#SM1){ref-type="supplementary-material"}; in kcal/gram of body weight). Consequently, the individual cumulative energy intake during 1-week HFD, hereinafter referred to as the "feeding response," ranged from 3.96 to 6.92 kcal/g (Figure [S1C](#SM1){ref-type="supplementary-material"}). According to this response, we identified by a median split HFD-intolerant mice with high feeding response due to slow normalization, and HFD-tolerant mice with low feeding response due to fast normalization (Figures [1A,B](#F1){ref-type="fig"}). The two groups of mice were initially undistinguishable with respect to their energy intake on standard diet or to their initial body weight (Figures [1C,D](#F1){ref-type="fig"}). On HFD, tolerant mice normalized their energy intake in only 2 days after HFD introduction, whereas intolerant mice normalized it after 10 days (Figure [1E](#F1){ref-type="fig"}; in kcal/gram of body weight). After 2 weeks on HFD, energy intake was normalized for all mice. Nevertheless, intolerant mice kept on HFD for a long term had further episodic increases in raw energy intake which appeared after 5 weeks on HFD (Figure [1E](#F1){ref-type="fig"}; in kcal). Therefore, the cumulative energy intake over 3 months with HFD was significantly higher in intolerant mice than in tolerant mice (Figure [1F](#F1){ref-type="fig"}). Moreover, the longitudinal follow-up showed that body weight of intolerant mice maintained on HFD increased strongly after 8 weeks in comparison to tolerant mice (Figure [1G](#F1){ref-type="fig"}). Hence, the body weight gain between the two groups of mice was significantly different after 3 months on HFD (Figure [1H](#F1){ref-type="fig"}). Importantly, the terminal body weight gain was positively correlated with the feeding response to HFD (Figure [1I](#F1){ref-type="fig"}). By contrast, it was not correlated with the initial energy intake on standard diet or with the terminal energy intake on HFD (Figures [1J,K](#F1){ref-type="fig"}). These results indicated that the homeostatic feeding response to an acute HFD challenge in mice is a latent trait predictive of the propensity to gain weight under persistent caloric pressure.

![Individual differences in the homeostatic feeding response to HFD reveal susceptibility to diet-induced obesity. **(A)** Energy intake per gram of body weight of HFD-tolerant (*n* = 16) and HFD-intolerant (*n* = 15) mice during 1-week HFD (^\*\*^*p* \< 0.01, HFD-tolerant vs. HFD-intolerant mice; two-way ANOVA and Bonferroni *post-hoc* test). **(B)** Cumulative energy intake per gram of body weight of HFD-tolerant and HFD-intolerant mice after 1 week on HFD (^\*\*\*^*p* \< 0.001; Mann Whitney test). **(C,D)** Initial energy intake per gram of body weight and body weight of HFD-tolerant and HFD-intolerant mice were similar on standard chow, i.e., before HFD introduction. **(E)** Energy intake of HFD-tolerant and HFD-intolerant mice during 13 weeks-HFD (^\*^*p* \< 0.05, ^\*\*\*^*p* \< 0.001, HFD-tolerant vs. HFD-intolerant mice; two-way ANOVA and Bonferroni *post-hoc* test). **(F)** Total energy intake of HFD-tolerant and HFD-intolerant mice after 3-month HFD (^\*\*\*^*p* \< 0.001; unpaired *t*-test). **(G)** Body weight of HFD-tolerant and HFD-intolerant mice during 13-week HFD (^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, HFD-tolerant vs. HFD-intolerant mice; two-way ANOVA and Bonferroni *post-hoc* test). **(H)** Body weight gain of HFD-tolerant and HFD-intolerant mice after 13-week HFD (^\*\*^*p* \< 0.01; unpaired *t*-test). **(I)** Correlation analysis between the acute feeding response to HFD and the body weight gain after 3-month HFD. HFD-tolerant mice are in gray, HFD-intolerant mice are in red (*p* \< 0.018; linear regression). **(J)** Correlation analysis between the initial energy intake on standard diet and the body weight gain after 3-month HFD. **(K)** Correlation analysis between the terminal energy intake on HFD and the body weight gain after 3-month HFD. All results are mean ± SEM.](fnut-05-00125-g0001){#F1}

Relation Between Fat Tolerance and Hypothalamus Polysialylation
---------------------------------------------------------------

Identification of individuals prone to obesity before the onset of the disease allows investigation of the biological underpinnings of susceptibility to obesity and makes possible the discovery of biological risk factors. Pre-existing differences in brain circuits controlling appetite and energy homeostasis might account for the vulnerability to common obesity ([@B17], [@B18]). Recent genetic studies formally implicated the brain in obesity pathology and pinpointed neuronal genes regulating synaptic plasticity ([@B12], [@B19], [@B20]). Moreover, rodent data consistently evidenced alterations of neural function and plasticity in brain feeding circuits in animals genetically predisposed to obesity ([@B21], [@B22]). Thus, we hypothesized that innate alteration in molecules involved in brain neuroplasticity would confer risk for obesity.

The polysialic acid-neural cell adhesion molecule (PSA-NCAM) is a cell-surface molecule that promotes various plasticity-related changes in brain circuits ([@B23]). We recently identified PSA-NCAM in the hypothalamus as a permissive factor for the brain control of energy balance ([@B16], [@B24], [@B25]). We therefore postulated that low level of hypothalamic PSA-NCAM would incite vulnerability to obesity. To test this hypothesis, we identified in a second cohort of mice (*n* = 14), HFD-tolerant and HFD-intolerant individuals according to their feeding response to 1-week HFD and then we examined the concentration of PSA-NCAM in the medio-basal hypothalamus (MBH) collected after this oral fat tolerance test. Intolerant mice showed significant lower levels of hypothalamic PSA-NCAM in comparison to tolerant mice (Figure [2](#F2){ref-type="fig"}; tolerant: 684.7 ± 59.4 ng/mg; intolerant: 505.9 ± 27.1 ng/mg; *p* = 0.038). As a reference, the constitutive level of PSA-NCAM in the MBH of control mice fed a standard diet was 508.5 ± 31 ng/mg protein (*n* = 16). The level of PSA-NCAM in the MBH of intolerant mice did not differ from the constitutive value. These data suggest that tolerant mice might have higher ability to mobilize PSA-NCAM to trigger synaptic plasticity in the hypothalamus than intolerant mice.

![Individual differences in the tolerance to HFD are linked to the level of hypothalamic PSA-NCAM. PSA-NCAM levels were measured in mediobasal hypothalamus after a 1-week HFD challenge allowing identification of HFD-tolerant and HFD-intolerant mice (*n* = 7 HFD-tolerant, *n* = 7 HFD-intolerant; ^\*^*p* \< 0.05; Mann Whitney test). Results are mean ± SEM.](fnut-05-00125-g0002){#F2}

Discussion {#s4}
==========

In this study, we measured the feeding response to 1-week HFD in mice. We found variability in the behavioral response with high responders who failed to rapidly normalize their energy intake during the metabolic challenge. High responders also gained more weight when they consumed the hypercaloric diet for a long time. Thus, the 1-week HFD challenge may be considered as a Dietary Fat Tolerance Test (DFTT) for identifying mice prone to nutritional obesity. Similar predictive tests have been used in the past showing that short-term response to HFD constitutes a phenotypic trait of metabolic flexibility which provides information on vulnerability to metabolic diseases ([@B8]--[@B11]). The present study further shows that the DFTT could be based on the behavioral response only, and does not necessarily imply collecting biopsies for metabolic investigation.

The DFTT might be relevant for investigating intrinsic factors that produce maladaptive eating disorders and vulnerability to obesity before the clinical onset of the disease. Some of these factors have been already evidenced, including efficiency of peripheral endocrinological and metabolic processes ([@B8], [@B9], [@B26], [@B27]), and responsivness of the dopaminergic system to food cues ([@B28]). Here we show that interindividual variability in the feeding response to short-term HFD is also linked to the intrahypothalamic PSA-NCAM signaling. This is in line with previous works from our group showing that experimental removal of hypothalamic PSA-NCAM increases the feeding response to HFD and the body weight gain ([@B16], [@B24]).

After the DFTT, intrahypothalamic PSA-NCAM content was elevated in HFD-tolerant mice, while it remained low and similar to the constitutive level in HFD-intolerant mice. This result suggests that inter-individual variability exists in the ability to upregulate PSA-NCAM production in the hypothalamus in response to the metabolic challenge, and that PSA-NCAM production was stimulated in HFD-tolerant mice. The source of variation of PSA-NCAM expression between HFD-tolerant and -intolerant animals is not known. Similar intrinsic differences in healthy animals have been already reported, linking the level of prefrontal PSA-NCAM to the susceptibility for addiction-related behaviors ([@B29]). Interindividual differences in learning-induced PSA-NCAM levels in the hippocampus is also linked to learning ability in rats ([@B30]). Interestingly, acute stress that predisposes young rats to mood and anxiety disorders during adulthood, as well as chronic stress in adult, cause dramatic alteration in PSA-NCAM expression in the limbic system ([@B31], [@B32]). These results show that brain PSA-NCAM synthesis is affected not only by genetic heritage but also by experience. Since litter size and maternal care are early determinants of vulnerability to obesity ([@B33]--[@B36]), PSA-NCAM variation in our model might by linked to perinatal experiences. At the molecular level, biosynthesis of PSA-NCAM in adult brain requires successive biochemical reactions, which are catalyzed by enzymes including UDP-GlcNAc 2-epimerase/ManNAc kinase and polysialyltransferase 1, encoded by *Gne* and *St8sia4* genes, respectively. One can propose that these genes might be differentially upregulated on HFD depending on individuals. Gene polymorphism association studies and epigenetic research on these specific genes in murine models and in humans are thus promising research to increase our knowledge on obesity susceptibility.

In several models of neuropsychological disorders, the loss of neural PSA-NCAM alters physiological defenses, exacerbates symptoms or worsens the disease ([@B29], [@B37]--[@B40]), pointing out the potential protective role of PSA-NCAM against brain dysfunctions involving a plasticity-related component. In previous works, we found that removal of hypothalamic PSA is sufficient to alter short-term homeostatic responses to dietary fat and increase body weight gain on a long term ([@B16], [@B24], [@B25]), confirming that hypothalamic PSA-NCAM is critical to maintain energy homeostasis upon metabolic challenge. Together, these data suggest a causal link between hypothalamic PSA-NCAM and the propensity for obesity. Given the role of PSA-NCAM in brain plasticity ([@B23], [@B41]), our findings further strengthen the concept that factors controlling neural plasticity are critical in the individual susceptibility to develop overweight with obesogenic foods ([@B22], [@B42], [@B43]). Consistently, a growing body of evidence indicates that weight gain in human is associated to genes encoding plasticity-related molecules ([@B12], [@B19], [@B20], [@B44]--[@B47]).

Future research is now needed to understand molecular basis of inter-individual heterogeneity in hypothalamic PSA-NCAM level and to identify life stressors that influence the expression of this factor in the hypothalamus.
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###### 

Acute feeding response of HFD-fed mice. **(A)** Average homeostatic feeding response to HFD in 2-month old male mice (C57Bl/6JOla) (*n* = 31; ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, and ^\*\*\*^*p* \< 0.001; one-way ANOVA for repeated measures followed by multiple comparison Dunnett *post-hoc* test vs. day 0). **(B)** Graphical representation of the individual feeding responses to 1-week HFD in 2-month old male mice (C57Bl/6JOla) (*n* = 31). **(C)** Plotting of the cumulative energy intake of mice on HFD for 1 week. Median split separated HFD-tolerant mice with low feeding response (gray; *n* = 16) and HFD-intolerant mice with high feeding response (red; *n* = 15).
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